{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "21", "@timestamp": "2021-10-21T20:46:30.000030-04:00", "@year": "2021", "@month": "10"}, "ait:date-sort": {"@day": "15", "@year": "2016", "@month": "08"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"country": "Thailand", "address-part": "Rama IV Road", "postal-code": "10330", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Division of Infectious Diseases"}, {"$": "Department of Pediatrics"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "104425637"}, "@dptid": "104425637"}, "author": [{"ce:given-name": "Thanyawee", "preferred-name": {"ce:given-name": "Thanyawee", "ce:initials": "T.", "ce:surname": "Puthanakit", "ce:indexed-name": "Puthanakit T."}, "@seq": "1", "ce:initials": "T.", "@_fa": "true", "@type": "auth", "ce:surname": "Puthanakit", "@auid": "8071686900", "ce:indexed-name": "Puthanakit T."}]}, {"affiliation": {"country": "Taiwan", "@afid": "60073385", "@country": "twn", "city": "Taipei", "organization": [{"$": "Department of Pediatrics"}, {"$": "National Taiwan University Hospital"}, {"$": "College of Medicine"}, {"$": "National Taiwan University"}], "affiliation-id": [{"@afid": "60073385", "@dptid": "113206157"}, {"@afid": "60005429"}, {"@afid": "60025370"}], "@dptid": "113206157"}, "author": [{"ce:given-name": "Li-Min", "preferred-name": {"ce:given-name": "Li Min", "ce:initials": "L.M.", "ce:surname": "Huang", "ce:indexed-name": "Huang L.M."}, "@seq": "2", "ce:initials": "L.-M.", "@date-locked": "2018-04-17T05:35:36.335", "@_fa": "true", "@type": "auth", "ce:surname": "Huang", "@auid": "7404736430", "ce:indexed-name": "Huang L.-M."}]}, {"affiliation": {"country": "Taiwan", "@afid": "60073391", "@country": "twn", "city": "Kweishan, Taoyuan", "organization": [{"$": "Division of Pediatric Infectious Diseases"}, {"$": "Department of Pediatrics"}, {"$": "Chang Gung Children's Hospital"}, {"$": "Chang Gung University College of Medicine"}], "affiliation-id": [{"@afid": "60073391", "@dptid": "113340936"}, {"@afid": "60003934"}], "@dptid": "113340936"}, "author": [{"ce:given-name": "Cheng-Hsun", "preferred-name": {"ce:given-name": "Cheng Hsun", "ce:initials": "C.H.", "ce:surname": "Chiu", "ce:indexed-name": "Chiu C.H."}, "@seq": "3", "ce:initials": "C.-H.", "@date-locked": "2019-06-05T21:54:26.365", "@_fa": "true", "@type": "auth", "ce:surname": "Chiu", "@auid": "13310132600", "ce:indexed-name": "Chiu C.-H."}]}, {"affiliation": {"country": "Taiwan", "@afid": "60104361", "@country": "twn", "city": "Taipei", "organization": [{"$": "Department of Pediatrics"}, {"$": "Cheng Hsin General Hospital"}], "affiliation-id": {"@afid": "60104361", "@dptid": "113392726"}, "@dptid": "113392726"}, "author": [{"ce:given-name": "Ren-Bin", "preferred-name": {"ce:given-name": "Ren Bin", "ce:initials": "R.B.", "ce:surname": "Tang", "ce:indexed-name": "Tang R.B."}, "@seq": "4", "ce:initials": "R.-B.", "@_fa": "true", "@type": "auth", "ce:surname": "Tang", "@auid": "7202300282", "ce:indexed-name": "Tang R.-B."}]}, {"affiliation": {"country": "Germany", "@afid": "101312952", "@country": "deu", "city": "Stiftung Juliusspital, W\u00fcrzburg", "organization": {"$": "Central Laboratory and Vaccination Centre"}, "affiliation-id": {"@afid": "101312952"}}, "author": [{"ce:given-name": "Tino F.", "preferred-name": {"ce:given-name": "Tino F.", "ce:initials": "T.F.", "ce:surname": "Schwarz", "ce:indexed-name": "Schwarz T.F."}, "@seq": "5", "ce:initials": "T.F.", "@_fa": "true", "@type": "auth", "ce:surname": "Schwarz", "@auid": "55956700100", "ce:indexed-name": "Schwarz T.F."}]}, {"affiliation": {"country": "Italy", "@afid": "60030318", "@country": "ita", "city": "Milan", "organization": [{"$": "Pediatric Highly Intensive Care Unit"}, {"$": "Department of Pathophysiology and Transplantation"}, {"$": "Universit\u00e0 degli Studi di Milano"}, {"$": "Fondazione IRCCS C\u00e1 Granda Ospedale Maggiore Policlinico"}], "affiliation-id": [{"@afid": "60030318", "@dptid": "104534016"}, {"@afid": "60007067"}], "@dptid": "104534016"}, "author": [{"ce:given-name": "Susanna", "preferred-name": {"ce:given-name": "Susanna", "ce:initials": "S.", "ce:surname": "Esposito", "ce:indexed-name": "Esposito S."}, "@seq": "6", "ce:initials": "S.", "@date-locked": "2018-07-04T10:03:57.697", "@_fa": "true", "@type": "auth", "ce:surname": "Esposito", "@auid": "57202226520", "ce:indexed-name": "Esposito S."}]}, {"affiliation": {"country": "Canada", "@afid": "110425674", "@country": "can", "city": "Sherbrooke", "organization": {"$": "QandT Research Incorporated"}, "affiliation-id": {"@afid": "110425674"}, "state": "QC"}, "author": [{"ce:given-name": "Louise", "preferred-name": {"ce:given-name": "Louise", "ce:initials": "L.", "ce:surname": "Frenette", "ce:indexed-name": "Frenette L."}, "@seq": "7", "ce:initials": "L.", "@_fa": "true", "@type": "auth", "ce:surname": "Frenette", "@auid": "36090013900", "ce:indexed-name": "Frenette L."}]}, {"affiliation": {"country": "Italy", "@afid": "60027298", "@country": "ita", "organization": [{"$": "Dipartimento di Pediatria"}, {"$": "Azienda Ospedaliera Universitaria di Padova"}], "affiliation-id": {"@afid": "60027298", "@dptid": "112691879"}, "@dptid": "112691879"}, "author": [{"ce:given-name": "Carlo", "preferred-name": {"ce:given-name": "Carlo", "ce:initials": "C.", "ce:surname": "Giaquinto", "ce:indexed-name": "Giaquinto C."}, "@seq": "8", "ce:initials": "C.", "@_fa": "true", "@type": "auth", "ce:surname": "Giaquinto", "@auid": "7006585659", "ce:indexed-name": "Giaquinto C."}]}, {"affiliation": {"country": "Canada", "@afid": "60015913", "@country": "can", "city": "Halifax", "organization": [{"$": "Canadian Center for Vaccinology"}, {"$": "IWK Health Centre and NovaScotia Health Authority"}, {"$": "Dalhousie University"}], "affiliation-id": [{"@afid": "60015913"}, {"@afid": "60190877"}, {"@afid": "60025341"}]}, "author": [{"ce:given-name": "Shelly", "preferred-name": {"ce:given-name": "Shelly", "ce:initials": "S.", "ce:surname": "McNeil", "ce:indexed-name": "McNeil S."}, "@seq": "9", "ce:initials": "S.", "@date-locked": "2018-06-10T21:24:08.497", "@_fa": "true", "@type": "auth", "ce:surname": "McNeil", "@auid": "7004978550", "ce:indexed-name": "McNeil S."}]}, {"affiliation": {"country": "Canada", "@afid": "111375275", "@country": "can", "city": "Sudbury", "organization": {"$": "Medicor Research Inc"}, "affiliation-id": {"@afid": "111375275"}, "state": "ON"}, "author": [{"ce:given-name": "Paul", "preferred-name": {"ce:given-name": "Paul", "ce:initials": "P.", "ce:surname": "Rheault", "ce:indexed-name": "Rheault P."}, "@seq": "10", "ce:initials": "P.", "@_fa": "true", "@type": "auth", "ce:surname": "Rheault", "@auid": "57189256240", "ce:indexed-name": "Rheault P."}]}, {"affiliation": {"country": "Italy", "@afid": "60003700", "@country": "ita", "organization": [{"$": "Department of Health Sciences"}, {"$": "School of Medical and Pharmaceutical Sciences"}, {"$": "Vaccines and Clinical Trials Unit"}, {"$": "IRCCS AOU San Martino-IST"}, {"$": "University of Genoa"}], "affiliation-id": [{"@afid": "60003700", "@dptid": "126433162"}, {"@afid": "60025153"}, {"@afid": "60107402"}], "@dptid": "126433162"}, "author": [{"ce:given-name": "Paolo", "preferred-name": {"ce:given-name": "Paolo", "ce:initials": "P.", "ce:surname": "Durando", "ce:indexed-name": "Durando P."}, "@seq": "11", "ce:initials": "P.", "@_fa": "true", "@type": "auth", "ce:surname": "Durando", "@auid": "8846475200", "ce:indexed-name": "Durando P."}]}, {"affiliation": {"country": "Czech Republic", "@afid": "117443926", "@country": "cze", "city": "Bavaria", "organization": {"$": "Pediatric Office Dr. Med. Michael Horn"}, "affiliation-id": {"@afid": "117443926"}}, "author": [{"ce:given-name": "Michael", "preferred-name": {"ce:given-name": "Michael", "ce:initials": "M.", "ce:surname": "Horn", "ce:indexed-name": "Horn M."}, "@seq": "12", "ce:initials": "M.", "@_fa": "true", "@type": "auth", "ce:surname": "Horn", "@auid": "57191341897", "ce:indexed-name": "Horn M."}]}, {"affiliation": {"country": "Germany", "@afid": "60024805", "@date-locked": "2021-09-18T13:15:05.481", "@country": "deu", "organization": [{"$": "Department of Obstetrics and Gynecology"}, {"$": "Freiburg Medical School"}], "affiliation-id": {"@afid": "60024805", "@dptid": "109480519"}, "@dptid": "109480519"}, "author": [{"ce:given-name": "Maximilian", "preferred-name": {"ce:given-name": "Maximilian", "ce:initials": "M.", "ce:surname": "Klar", "ce:indexed-name": "Klar M."}, "@seq": "13", "ce:initials": "M.", "@_fa": "true", "@type": "auth", "ce:surname": "Klar", "@auid": "6701599065", "ce:indexed-name": "Klar M."}]}, {"affiliation": {"country": "Belgium", "@afid": "60111446", "@country": "bel", "city": "Rixensart", "organization": {"$": "GSK Vaccines"}, "affiliation-id": {"@afid": "60111446"}}, "author": [{"ce:given-name": "Sylviane", "preferred-name": {"ce:given-name": "Sylviane", "ce:initials": "S.", "ce:surname": "Poncelet", "ce:indexed-name": "Poncelet S."}, "@seq": "14", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:surname": "Poncelet", "@auid": "6506528944", "ce:indexed-name": "Poncelet S."}, {"ce:given-name": "St\u00e9phanie", "preferred-name": {"ce:given-name": "St\u00e9phanie", "ce:initials": "S.", "ce:surname": "De Simoni", "ce:indexed-name": "De Simoni S."}, "@seq": "15", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:surname": "De Simoni", "@auid": "57189925256", "ce:indexed-name": "De Simoni S."}]}, {"affiliation": {"country": "Belgium", "@afid": "60111446", "@country": "bel", "city": "Wavre", "organization": {"$": "GSK Vaccines"}, "affiliation-id": {"@afid": "60111446"}}, "author": [{"ce:given-name": "Damien", "preferred-name": {"ce:given-name": "Damien", "ce:initials": "D.", "ce:surname": "Friel", "ce:indexed-name": "Friel D."}, "@seq": "16", "ce:initials": "D.", "@_fa": "true", "@type": "auth", "ce:surname": "Friel", "@auid": "56906794500", "ce:indexed-name": "Friel D."}, {"ce:given-name": "Benoit", "preferred-name": {"ce:given-name": "Benoit", "ce:initials": "B.", "ce:surname": "De Muynck", "ce:indexed-name": "De Muynck B."}, "@seq": "17", "ce:initials": "B.", "@_fa": "true", "@type": "auth", "ce:surname": "De Muynck", "@auid": "25947383400", "ce:indexed-name": "De Muynck B."}, {"ce:given-name": "Dominique", "preferred-name": {"ce:given-name": "Dominique", "ce:initials": "D.", "ce:surname": "Descamps", "ce:indexed-name": "Descamps D."}, "@seq": "20", "ce:initials": "D.", "@_fa": "true", "@type": "auth", "ce:surname": "Descamps", "@auid": "16311641500", "ce:indexed-name": "Descamps D."}, {"ce:given-name": "Florence", "preferred-name": {"ce:given-name": "Florence", "ce:initials": "F.", "ce:surname": "Thomas", "ce:indexed-name": "Thomas F."}, "@seq": "21", "ce:initials": "F.", "@_fa": "true", "@type": "auth", "ce:surname": "Thomas", "@auid": "35996136600", "ce:indexed-name": "Thomas F."}, {"ce:given-name": "Frank", "preferred-name": {"ce:given-name": "Frank", "ce:initials": "F.", "ce:surname": "Struyf", "ce:indexed-name": "Struyf F."}, "@seq": "22", "ce:initials": "F.", "@_fa": "true", "@type": "auth", "ce:surname": "Struyf", "@auid": "6603247840", "ce:indexed-name": "Struyf F."}]}, {"affiliation": {"country": "India", "@afid": "60111469", "@country": "ind", "city": "Bangalore, Karnataka", "organization": {"$": "GSK Pharmaceuticals India Ltd."}, "affiliation-id": {"@afid": "60111469"}}, "author": [{"ce:given-name": "Pemmaraju V.", "preferred-name": {"ce:given-name": "Pemmaraju V.", "ce:initials": "P.V.", "ce:surname": "Suryakiran", "ce:indexed-name": "Suryakiran P.V."}, "@seq": "18", "ce:initials": "P.V.", "@_fa": "true", "@type": "auth", "ce:surname": "Suryakiran", "@auid": "26022588400", "ce:indexed-name": "Suryakiran P.V."}]}, {"affiliation": {"country": "Belgium", "@afid": "60111446", "@country": "bel", "city": "Wavre", "organization": {"$": "Chiltern International for GSK"}, "affiliation-id": {"@afid": "60111446"}}, "author": [{"ce:given-name": "Marjan", "preferred-name": {"ce:given-name": "Marjan", "ce:initials": "M.", "ce:surname": "Hezareh", "ce:indexed-name": "Hezareh M."}, "@seq": "19", "ce:initials": "M.", "@_fa": "true", "@type": "auth", "ce:surname": "Hezareh", "@auid": "57194243463", "ce:indexed-name": "Hezareh M."}]}], "citation-title": "Randomized open trial comparing 2-dose regimens of the human papillomavirus 16/18 as04-adjuvanted vaccine in girls aged 9-14 years versus a 3-dose regimen in women aged 15-25 years", "abstracts": "\u00a9 The Author 2016.Background. This randomized, open trial compared regimens including 2 doses (2D) of human papillomavirus (HPV) 16/18 AS04-adjuvanted vaccine in girls aged 9-14 years with one including 3 doses (3D) in women aged 15-25 years. Methods. Girls aged 9-14 years were randomized to receive 2D at months 0 and 6 (M0,6; (n = 550) or months 0 and 12 (M0,12; n = 415), and women aged 15-25 years received 3D at months 0, 1, and 6 (n = 482). End points included noninferiority of HPV-16/ 18 antibodies by enzyme-linked immunosorbent assay for 2D (M0,6) versus 3D (primary), 2D (M0,12) versus 3D, and 2D (M0,6) versus 2D (M0,12); neutralizing antibodies; cell-mediated immunity; reactogenicity; and safety. Limits of noninferiority were predefined as <5% difference in seroconversion rate and <2-fold difference in geometric mean antibody titer ratio. Results. One month after the last dose, both 2D regimens in girls aged 9-14 years were noninferior to 3D in women aged 15-25 years and 2D (M0,12) was noninferior to 2D (M0,6). Geometric mean antibody titer ratios (3D/2D) for HPV-16 and HPV-18 were 1.09 (95% confidence interval, .97-1.22) and 0.85 (.76-.95) for 2D (M0,6) versus 3D and 0.89 (.79-1.01) and 0.75 (.67-.85) for 2D (M0,12) versus 3D. The safety profile was clinically acceptable in all groups. Conclusions. The 2D regimens for the HPV-16/18 AS04-adjuvanted vaccine in girls aged 9-14 years (M0,6 or M0,12) elicited HPV-16/18 immune responses that were noninferior to 3D in women aged 15-25 years.", "correspondence": {"affiliation": {"country": "Thailand", "address-part": "Rama IV Road", "postal-code": "10330", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Division of Infectious Diseases"}, {"$": "Department of Pediatrics"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}]}, "person": {"ce:given-name": "Thanyawee", "ce:initials": "T.", "ce:surname": "Puthanakit", "ce:indexed-name": "Puthanakit T."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "2-dose schedule", "@xml:lang": "eng"}, {"$": "Adjuvant System containing 50 ?g 3-O-desacyl-4?-monophosphoryl lipid A (MPL) adsorbed on aluminum salt (500 ?g Al3+)", "@xml:lang": "eng"}, {"$": "AS04", "@xml:lang": "eng"}, {"$": "Cell-mediated immunity", "@xml:lang": "eng"}, {"$": "Cervical cancer", "@xml:lang": "eng"}, {"$": "CMI", "@xml:lang": "eng"}, {"$": "Geometric mean antibody titer", "@xml:lang": "eng"}, {"$": "GMT", "@xml:lang": "eng"}, {"$": "HPV", "@xml:lang": "eng"}, {"$": "Human papillomavirus", "@xml:lang": "eng"}, {"$": "IgG", "@xml:lang": "eng"}, {"$": "Immunogenicity", "@xml:lang": "eng"}]}, "citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"website": {"ce:e-address": {"$": "http://jid.oxfordjournals.org/content/current", "@type": "email"}}, "translated-sourcetitle": {"$": "Journal of Infectious Diseases", "@xml:lang": "eng"}, "volisspag": {"voliss": {"@volume": "214", "@issue": "4"}, "pagerange": {"@first": "525", "@last": "536"}}, "@type": "j", "sourcetitle": "Journal of Infectious Diseases", "publicationdate": {"month": "08", "year": "2016", "date-text": {"@xfab-added": "true", "$": "15 August 2016"}, "day": "15"}, "codencode": "JIDIA", "sourcetitle-abbrev": "J. Infect. Dis.", "@country": "gbr", "issn": [{"$": "15376613", "@type": "electronic"}, {"$": "00221899", "@type": "print"}], "publicationyear": {"@first": "2016"}, "publisher": {"publishername": "Oxford University Press"}, "@srcid": "22440"}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "CABSCLASS", "classification": {"classification-code": "86.7.4.11", "classification-description": "IMMUNOLOGY AND INFECTIOUS DISEASES; IMMUNITY TO INFECTION; Medical and Veterinary Virology; Human vaccines"}}, {"@type": "EMCLASS", "classification": [{"classification-code": "26", "classification-description": "Immunology, Serology and Transplantation"}, {"classification-code": "37", "classification-description": "Drug Literature Index"}, {"classification-code": "38", "classification-description": "Adverse Reactions Titles"}, {"classification-code": "4", "classification-description": "Microbiology: Bacteriology, Mycology, Parasitology and Virology"}]}, {"@type": "ASJC", "classification": [{"$": "2723"}, {"$": "2725"}]}, {"@type": "SUBJABBR", "classification": "MEDI"}]}, "chemicalgroup": {"chemicals": [{"@source": "esbd", "chemical": [{"cas-registry-number": [{"$": "1330-44-5"}, {"$": "20257-20-9"}, {"$": "21645-51-2"}, {"$": "80206-84-4"}], "chemical-name": "aluminum hydroxide"}, {"cas-registry-number": "95991-05-2", "chemical-name": "lipid A"}]}, {"@source": "nlm", "chemical": [{"chemical-name": "Adjuvants, Immunologic"}, {"chemical-name": "Aluminum Hydroxide"}, {"chemical-name": "Antibodies, Neutralizing"}, {"chemical-name": "Antibodies, Viral"}, {"chemical-name": "ASO4 mixture"}, {"chemical-name": "Lipid A"}, {"chemical-name": "Papillomavirus Vaccines"}]}]}}}, "item-info": {"copyright": {"$": "Copyright 2018 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "dbcollection": [{"$": "CABS"}, {"$": "EMBASE"}, {"$": "MEDL"}, {"$": "MOSYEA"}, {"$": "NURSNG"}, {"$": "REAXYSCAR"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}], "history": {"date-created": {"@day": "24", "@timestamp": "BST 11:38:36", "@year": "2018", "@month": "08"}}, "itemidlist": {"itemid": [{"$": "612435204", "@idtype": "PUI"}, {"$": "2016332019", "@idtype": "CABS"}, {"$": "655961615", "@idtype": "CAR-ID"}, {"$": "20160701208", "@idtype": "EMBASE"}, {"$": "26908726", "@idtype": "MEDL"}, {"$": "2016121886", "@idtype": "MOSYEA"}, {"$": "2016336911", "@idtype": "NURSNG"}, {"$": "20162019972", "@idtype": "REAXYSCAR"}, {"$": "84988975003", "@idtype": "SCP"}, {"$": "84988975003", "@idtype": "SGR"}, {"$": "616340698", "@idtype": "PUIsecondary"}], "ce:doi": "10.1093/infdis/jiw036"}}, "tail": {"bibliography": {"@refcount": "40", "reference": [{"ref-fulltext": "Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev 2003; 16:1-17.", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2003"}, "ref-title": {"ref-titletext": "Human papillomavirus and cervical cancer"}, "refd-itemidlist": {"itemid": {"$": "0037243946", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "16"}, "pagerange": {"@first": "1", "@last": "17"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.M.", "@_fa": "true", "ce:surname": "Burd", "ce:indexed-name": "Burd E.M."}]}, "ref-sourcetitle": "Clin Microbiol Rev"}}, {"ref-fulltext": "Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85:958-64.", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "1993"}, "ref-title": {"ref-titletext": "Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia"}, "refd-itemidlist": {"itemid": {"$": "0027215213", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "85"}, "pagerange": {"@first": "958", "@last": "964"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.H.", "@_fa": "true", "ce:surname": "Schiffman", "ce:indexed-name": "Schiffman M.H."}, {"@seq": "2", "ce:initials": "H.M.", "@_fa": "true", "ce:surname": "Bauer", "ce:indexed-name": "Bauer H.M."}, {"@seq": "3", "ce:initials": "R.N.", "@_fa": "true", "ce:surname": "Hoover", "ce:indexed-name": "Hoover R.N."}], "et-al": null}, "ref-sourcetitle": "J Natl Cancer Inst"}}, {"ref-fulltext": "Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-9.", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "1999"}, "ref-title": {"ref-titletext": "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide"}, "refd-itemidlist": {"itemid": {"$": "0032840918", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "189"}, "pagerange": {"@first": "12", "@last": "19"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.M.", "@_fa": "true", "ce:surname": "Walboomers", "ce:indexed-name": "Walboomers J.M."}, {"@seq": "2", "ce:initials": "M.V.", "@_fa": "true", "ce:surname": "Jacobs", "ce:indexed-name": "Jacobs M.V."}, {"@seq": "3", "ce:initials": "M.M.", "@_fa": "true", "ce:surname": "Manos", "ce:indexed-name": "Manos M.M."}], "et-al": null}, "ref-sourcetitle": "J Pathol"}}, {"ref-fulltext": "Jit M, Brisson M, Laprise JF, Choi YH. Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model. BMJ 2015; 350:g7584.", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Comparison of two dose and three dose human papillomavirus vaccine schedules: Cost effectiveness analysis based on transmission model"}, "refd-itemidlist": {"itemid": {"$": "84921326276", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "350"}, "pagerange": {"@first": "g7584"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Jit", "ce:indexed-name": "Jit M."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Brisson", "ce:indexed-name": "Brisson M."}, {"@seq": "3", "ce:initials": "J.F.", "@_fa": "true", "ce:surname": "Laprise", "ce:indexed-name": "Laprise J.F."}, {"@seq": "4", "ce:initials": "Y.H.", "@_fa": "true", "ce:surname": "Choi", "ce:indexed-name": "Choi Y.H."}]}, "ref-sourcetitle": "BMJ"}}, {"ref-fulltext": "Pedersen C, Petaja T, Strauss G, et al. Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant. J Adolesc Health 2007; 40:564-71.", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant"}, "refd-itemidlist": {"itemid": {"$": "34248631118", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "40"}, "pagerange": {"@first": "564", "@last": "571"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Pedersen", "ce:indexed-name": "Pedersen C."}, {"@seq": "2", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Petaja", "ce:indexed-name": "Petaja T."}, {"@seq": "3", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Strauss", "ce:indexed-name": "Strauss G."}], "et-al": null}, "ref-sourcetitle": "J Adolesc Health"}}, {"ref-fulltext": "Block SL, Nolan T, Sattler C, et al. Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics 2006; 118:2135-45.", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-title": {"ref-titletext": "Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women"}, "refd-itemidlist": {"itemid": {"$": "33750938518", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "118"}, "pagerange": {"@first": "2135", "@last": "2145"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.L.", "@_fa": "true", "ce:surname": "Block", "ce:indexed-name": "Block S.L."}, {"@seq": "2", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Nolan", "ce:indexed-name": "Nolan T."}, {"@seq": "3", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Sattler", "ce:indexed-name": "Sattler C."}], "et-al": null}, "ref-sourcetitle": "Pediatrics"}}, {"ref-fulltext": "Harper DM, Franco EL, Wheeler C, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004; 364:1757-65.", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomised controlled trial"}, "refd-itemidlist": {"itemid": {"$": "8444249386", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "364"}, "pagerange": {"@first": "1757", "@last": "1765"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.M.", "@_fa": "true", "ce:surname": "Harper", "ce:indexed-name": "Harper D.M."}, {"@seq": "2", "ce:initials": "E.L.", "@_fa": "true", "ce:surname": "Franco", "ce:indexed-name": "Franco E.L."}, {"@seq": "3", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Wheeler", "ce:indexed-name": "Wheeler C."}], "et-al": null}, "ref-sourcetitle": "Lancet"}}, {"ref-fulltext": "Harper DM, Franco EL, Wheeler CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 2006; 367:1247-55.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-title": {"ref-titletext": "Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomised control trial"}, "refd-itemidlist": {"itemid": {"$": "33646058566", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "367"}, "pagerange": {"@first": "1247", "@last": "1255"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.M.", "@_fa": "true", "ce:surname": "Harper", "ce:indexed-name": "Harper D.M."}, {"@seq": "2", "ce:initials": "E.L.", "@_fa": "true", "ce:surname": "Franco", "ce:indexed-name": "Franco E.L."}, {"@seq": "3", "ce:initials": "C.M.", "@_fa": "true", "ce:surname": "Wheeler", "ce:indexed-name": "Wheeler C.M."}], "et-al": null}, "ref-sourcetitle": "Lancet"}}, {"ref-fulltext": "Paavonen J, Naud P, Salmeron J, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009; 374:301-14.", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women"}, "refd-itemidlist": {"itemid": {"$": "67651049056", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "374"}, "pagerange": {"@first": "301", "@last": "314"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Paavonen", "ce:indexed-name": "Paavonen J."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Naud", "ce:indexed-name": "Naud P."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Salmeron", "ce:indexed-name": "Salmeron J."}], "et-al": null}, "ref-sourcetitle": "Lancet"}}, {"ref-fulltext": "Lehtinen M, Paavonen J, Wheeler CM, et al. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol 2012; 13:89-99.", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial"}, "refd-itemidlist": {"itemid": {"$": "84855300842", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "13"}, "pagerange": {"@first": "89", "@last": "99"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Lehtinen", "ce:indexed-name": "Lehtinen M."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Paavonen", "ce:indexed-name": "Paavonen J."}, {"@seq": "3", "ce:initials": "C.M.", "@_fa": "true", "ce:surname": "Wheeler", "ce:indexed-name": "Wheeler C.M."}], "et-al": null}, "ref-sourcetitle": "Lancet Oncol"}}, {"ref-fulltext": "Wheeler CM, Castellsague X, Garland SM, et al. Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol 2012; 13:100-10.", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial"}, "refd-itemidlist": {"itemid": {"$": "84855309413", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "13"}, "pagerange": {"@first": "100", "@last": "110"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.M.", "@_fa": "true", "ce:surname": "Wheeler", "ce:indexed-name": "Wheeler C.M."}, {"@seq": "2", "ce:initials": "X.", "@_fa": "true", "ce:surname": "Castellsague", "ce:indexed-name": "Castellsague X."}, {"@seq": "3", "ce:initials": "S.M.", "@_fa": "true", "ce:surname": "Garland", "ce:indexed-name": "Garland S.M."}], "et-al": null}, "ref-sourcetitle": "Lancet Oncol"}}, {"ref-fulltext": "FUTURE II Study Group. Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection. J Infect Dis 2007; 196:1438-46.", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection"}, "refd-itemidlist": {"itemid": {"$": "38049008823", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "196"}, "pagerange": {"@first": "1438", "@last": "1446"}}, "ref-text": "FUTURE II Study Group", "ref-sourcetitle": "J Infect Dis"}}, {"ref-fulltext": "Ault KA, FUTURE II Study Group. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet 2007; 369:1861-8.", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: A combined analysis of four randomised clinical trials"}, "refd-itemidlist": {"itemid": {"$": "34249654115", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "369"}, "pagerange": {"@first": "1861", "@last": "1868"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.A.", "@_fa": "true", "ce:surname": "Ault", "ce:indexed-name": "Ault K.A."}]}, "ref-sourcetitle": "Lancet"}}, {"ref-fulltext": "Romanowski B, Schwarz TF, Ferguson LM, et al. Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule: results from a randomized study. Hum Vaccin 2011; 7:1374-86.", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule: Results from a randomized study"}, "refd-itemidlist": {"itemid": {"$": "84855184271", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "7"}, "pagerange": {"@first": "1374", "@last": "1386"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Romanowski", "ce:indexed-name": "Romanowski B."}, {"@seq": "2", "ce:initials": "T.F.", "@_fa": "true", "ce:surname": "Schwarz", "ce:indexed-name": "Schwarz T.F."}, {"@seq": "3", "ce:initials": "L.M.", "@_fa": "true", "ce:surname": "Ferguson", "ce:indexed-name": "Ferguson L.M."}], "et-al": null}, "ref-sourcetitle": "Hum Vaccin"}}, {"ref-fulltext": "Romanowski B, Schwarz TF, Ferguson LM, et al. Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination: results from a randomized study. Hum Vaccin Immunother 2014; 10:1155-65.", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination: Results from a randomized study"}, "refd-itemidlist": {"itemid": {"$": "84901396246", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "10"}, "pagerange": {"@first": "1155", "@last": "1165"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Romanowski", "ce:indexed-name": "Romanowski B."}, {"@seq": "2", "ce:initials": "T.F.", "@_fa": "true", "ce:surname": "Schwarz", "ce:indexed-name": "Schwarz T.F."}, {"@seq": "3", "ce:initials": "L.M.", "@_fa": "true", "ce:surname": "Ferguson", "ce:indexed-name": "Ferguson L.M."}], "et-al": null}, "ref-sourcetitle": "Hum Vaccin Immunother"}}, {"ref-fulltext": "Romanowski B, Schwarz TF, Ferguson L, et al. Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: five-year clinical data and modeling predictions from a randomized study. Hum Vaccin Immunother 2016; 12:20-9.", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-title": {"ref-titletext": "Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study"}, "refd-itemidlist": {"itemid": {"$": "84961805957", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "12"}, "pagerange": {"@first": "20", "@last": "29"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Romanowski", "ce:indexed-name": "Romanowski B."}, {"@seq": "2", "ce:initials": "T.F.", "@_fa": "true", "ce:surname": "Schwarz", "ce:indexed-name": "Schwarz T.F."}, {"@seq": "3", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Ferguson", "ce:indexed-name": "Ferguson L."}], "et-al": null}, "ref-sourcetitle": "Hum Vaccin Immunother"}}, {"ref-fulltext": "Dessy FJ, Giannini SL, Bougelet CA, et al. Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vaccine. Hum Vaccin 2008; 4:425-34.", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vaccine"}, "refd-itemidlist": {"itemid": {"$": "56149091686", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "4"}, "pagerange": {"@first": "425", "@last": "434"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "F.J.", "@_fa": "true", "ce:surname": "Dessy", "ce:indexed-name": "Dessy F.J."}, {"@seq": "2", "ce:initials": "S.L.", "@_fa": "true", "ce:surname": "Giannini", "ce:indexed-name": "Giannini S.L."}, {"@seq": "3", "ce:initials": "C.A.", "@_fa": "true", "ce:surname": "Bougelet", "ce:indexed-name": "Bougelet C.A."}], "et-al": null}, "ref-sourcetitle": "Hum Vaccin"}}, {"ref-fulltext": "Einstein MH, Baron M, Levin MJ, et al. Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years. Hum Vaccin 2011; 7:1359-73.", "@id": "18", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years"}, "refd-itemidlist": {"itemid": {"$": "84855169688", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "7"}, "pagerange": {"@first": "1359", "@last": "1373"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.H.", "@_fa": "true", "ce:surname": "Einstein", "ce:indexed-name": "Einstein M.H."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Baron", "ce:indexed-name": "Baron M."}, {"@seq": "3", "ce:initials": "M.J.", "@_fa": "true", "ce:surname": "Levin", "ce:indexed-name": "Levin M.J."}], "et-al": null}, "ref-sourcetitle": "Hum Vaccin"}}, {"ref-fulltext": "Boxus M, Lockman L, Fochesato M, et al. Antibody avidity measurements in recipients of Cervarix vaccine following a two-dose schedule or a three-dose schedule. Vaccine 2014; 32:3232-6.", "@id": "19", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Antibody avidity measurements in recipients of Cervarix vaccine following a two-dose schedule or a three-dose schedule"}, "refd-itemidlist": {"itemid": {"$": "84900447648", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "32"}, "pagerange": {"@first": "3232", "@last": "3236"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Boxus", "ce:indexed-name": "Boxus M."}, {"@seq": "2", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Lockman", "ce:indexed-name": "Lockman L."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Fochesato", "ce:indexed-name": "Fochesato M."}], "et-al": null}, "ref-sourcetitle": "Vaccine"}}, {"ref-fulltext": "Einstein MH, Baron M, Levin MJ, et al. Comparison of the immunogenicity and safety of CervarixTM and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years. Hum Vaccin 2009; 5:705-19.", "@id": "20", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Comparison of the immunogenicity and safety of CervarixTM and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years"}, "refd-itemidlist": {"itemid": {"$": "71649091113", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "5"}, "pagerange": {"@first": "705", "@last": "719"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.H.", "@_fa": "true", "ce:surname": "Einstein", "ce:indexed-name": "Einstein M.H."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Baron", "ce:indexed-name": "Baron M."}, {"@seq": "3", "ce:initials": "M.J.", "@_fa": "true", "ce:surname": "Levin", "ce:indexed-name": "Levin M.J."}], "et-al": null}, "ref-sourcetitle": "Hum Vaccin"}}, {"ref-fulltext": "Einstein MH, Baron M, Levin MJ, et al. Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: follow-up from months 12-24 in a phase III randomized study of healthy women aged 18-45 years. Hum Vaccin 2011; 7:1343-58.", "@id": "21", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: Follow-up from months 12-24 in a phase III randomized study of healthy women aged 18-45 years"}, "refd-itemidlist": {"itemid": {"$": "84855181757", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "7"}, "pagerange": {"@first": "1343", "@last": "1358"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.H.", "@_fa": "true", "ce:surname": "Einstein", "ce:indexed-name": "Einstein M.H."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Baron", "ce:indexed-name": "Baron M."}, {"@seq": "3", "ce:initials": "M.J.", "@_fa": "true", "ce:surname": "Levin", "ce:indexed-name": "Levin M.J."}], "et-al": null}, "ref-sourcetitle": "Hum Vaccin"}}, {"ref-fulltext": "Garcia-Sicilia J, Schwarz TF, Carmona A, et al. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine coadministered with combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine to girls and young women. J Adolesc Health 2010; 46:142-51.", "@id": "22", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine coadministered with combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine to girls and young women"}, "refd-itemidlist": {"itemid": {"$": "74549177126", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "46"}, "pagerange": {"@first": "142", "@last": "151"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Garcia-Sicilia", "ce:indexed-name": "Garcia-Sicilia J."}, {"@seq": "2", "ce:initials": "T.F.", "@_fa": "true", "ce:surname": "Schwarz", "ce:indexed-name": "Schwarz T.F."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Carmona", "ce:indexed-name": "Carmona A."}], "et-al": null}, "ref-sourcetitle": "J Adolesc Health"}}, {"ref-fulltext": "Schmeink CE. Co-administration of human papillomavirus-16/18 AS04-adjuvanted vaccine with hepatitis B vaccine: randomized study in healthy girls. Vaccine 2011; 29:9276-83.", "@id": "23", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Co-administration of human papillomavirus-16/18 AS04-adjuvanted vaccine with hepatitis B vaccine: Randomized study in healthy girls"}, "refd-itemidlist": {"itemid": {"$": "82555164963", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "29"}, "pagerange": {"@first": "9276", "@last": "9283"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.E.", "@_fa": "true", "ce:surname": "Schmeink", "ce:indexed-name": "Schmeink C.E."}]}, "ref-sourcetitle": "Vaccine"}}, {"ref-fulltext": "Pedersen C, Breindahl M, Aggarwal N, et al. Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls. J Adolesc Health 2012; 50:38-46.", "@id": "24", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Randomized trial: Immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls"}, "refd-itemidlist": {"itemid": {"$": "84055218378", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "50"}, "pagerange": {"@first": "38", "@last": "46"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Pedersen", "ce:indexed-name": "Pedersen C."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Breindahl", "ce:indexed-name": "Breindahl M."}, {"@seq": "3", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Aggarwal", "ce:indexed-name": "Aggarwal N."}], "et-al": null}, "ref-sourcetitle": "J Adolesc Health"}}, {"ref-fulltext": "Paavonen J, Jenkins D, Bosch FX, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007; 369:2161-70.", "@id": "25", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: An interim analysis of a phase III double-blind, randomised controlled trial"}, "refd-itemidlist": {"itemid": {"$": "34250850161", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "369"}, "pagerange": {"@first": "2161", "@last": "2170"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Paavonen", "ce:indexed-name": "Paavonen J."}, {"@seq": "2", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Jenkins", "ce:indexed-name": "Jenkins D."}, {"@seq": "3", "ce:initials": "F.X.", "@_fa": "true", "ce:surname": "Bosch", "ce:indexed-name": "Bosch F.X."}], "et-al": null}, "ref-sourcetitle": "Lancet"}}, {"ref-fulltext": "Stanley M. Immune responses to human papillomavirus. Vaccine 2006; 24: S16-22.", "@id": "26", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-title": {"ref-titletext": "Immune responses to human papillomavirus"}, "refd-itemidlist": {"itemid": {"$": "33644938245", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "24"}, "pagerange": {"@first": "S16", "@last": "S22"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Stanley", "ce:indexed-name": "Stanley M."}]}, "ref-sourcetitle": "Vaccine"}}, {"ref-fulltext": "Longet S, Schiller JT, Bobst M, Jichlinski P, Nardelli-Haefliger D. A murine genital-challenge model is a sensitive measure of protective antibodies against human papillomavirus infection. J Virol 2011; 85:13253-9.", "@id": "27", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "A murine genital-challenge model is a sensitive measure of protective antibodies against human papillomavirus infection"}, "refd-itemidlist": {"itemid": {"$": "84855823916", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "85"}, "pagerange": {"@first": "13253", "@last": "13259"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Longet", "ce:indexed-name": "Longet S."}, {"@seq": "2", "ce:initials": "J.T.", "@_fa": "true", "ce:surname": "Schiller", "ce:indexed-name": "Schiller J.T."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Bobst", "ce:indexed-name": "Bobst M."}, {"@seq": "4", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Jichlinski", "ce:indexed-name": "Jichlinski P."}, {"@seq": "5", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Nardelli-Haefliger", "ce:indexed-name": "Nardelli-Haefliger D."}]}, "ref-sourcetitle": "J Virol"}}, {"ref-fulltext": "Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002; 298:2199-202.", "@id": "28", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "Maintenance of serological memory by polyclonal activation of human memory B cells"}, "refd-itemidlist": {"itemid": {"$": "0037073930", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "298"}, "pagerange": {"@first": "2199", "@last": "2202"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "N.L.", "@_fa": "true", "ce:surname": "Bernasconi", "ce:indexed-name": "Bernasconi N.L."}, {"@seq": "2", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Traggiai", "ce:indexed-name": "Traggiai E."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Lanzavecchia", "ce:indexed-name": "Lanzavecchia A."}]}, "ref-sourcetitle": "Science"}}, {"ref-fulltext": "Crotty S, Felgner P, Davies H, et al. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 2003; 171:4969-73.", "@id": "29", "ref-info": {"ref-publicationyear": {"@first": "2003"}, "ref-title": {"ref-titletext": "Cutting edge: Long-term B cell memory in humans after smallpox vaccination"}, "refd-itemidlist": {"itemid": {"$": "0242495755", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "171"}, "pagerange": {"@first": "4969", "@last": "4973"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Crotty", "ce:indexed-name": "Crotty S."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Felgner", "ce:indexed-name": "Felgner P."}, {"@seq": "3", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Davies", "ce:indexed-name": "Davies H."}], "et-al": null}, "ref-sourcetitle": "J Immunol"}}, {"ref-fulltext": "Traggiai E, Puzone R, Lanzavecchia A. Antigen dependent and independent mechanisms that sustain serum antibody levels. Vaccine 2003; 21(suppl 2): S35-7.", "@id": "30", "ref-info": {"ref-publicationyear": {"@first": "2003"}, "ref-title": {"ref-titletext": "Antigen dependent and independent mechanisms that sustain serum antibody levels"}, "refd-itemidlist": {"itemid": {"$": "0037650212", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "21"}, "pagerange": {"@first": "S35", "@last": "S37"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Traggiai", "ce:indexed-name": "Traggiai E."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Puzone", "ce:indexed-name": "Puzone R."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Lanzavecchia", "ce:indexed-name": "Lanzavecchia A."}]}, "ref-sourcetitle": "Vaccine"}}, {"ref-fulltext": "Lazcano-Ponce E, Stanley M, Munoz N, et al. Overcoming barriers to HPV vaccination: non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months. Vaccine 2014; 32:725-32.", "@id": "31", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Overcoming barriers to HPV vaccination: Non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. A three-dose schedule at 21 months"}, "refd-itemidlist": {"itemid": {"$": "84893009653", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "32"}, "pagerange": {"@first": "725", "@last": "732"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Lazcano-Ponce", "ce:indexed-name": "Lazcano-Ponce E."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Stanley", "ce:indexed-name": "Stanley M."}, {"@seq": "3", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Munoz", "ce:indexed-name": "Munoz N."}], "et-al": null}, "ref-sourcetitle": "Vaccine"}}, {"ref-fulltext": "Kreimer AR, Rodriguez AC, Hildesheim A, et al. Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine. J Natl Cancer Inst 2011; 103:1444-51.", "@id": "32", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine"}, "refd-itemidlist": {"itemid": {"$": "80054087108", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "103"}, "pagerange": {"@first": "1444", "@last": "1451"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.R.", "@_fa": "true", "ce:surname": "Kreimer", "ce:indexed-name": "Kreimer A.R."}, {"@seq": "2", "ce:initials": "A.C.", "@_fa": "true", "ce:surname": "Rodriguez", "ce:indexed-name": "Rodriguez A.C."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Hildesheim", "ce:indexed-name": "Hildesheim A."}], "et-al": null}, "ref-sourcetitle": "J Natl Cancer Inst"}}, {"ref-fulltext": "Safaeian M, Porras C, Pan Y, et al. Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial. Cancer Prev Res (Phila) 2013; 6:1242-50.", "@id": "33", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial"}, "refd-itemidlist": {"itemid": {"$": "84886032410", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "6"}, "pagerange": {"@first": "1242", "@last": "1250"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Safaeian", "ce:indexed-name": "Safaeian M."}, {"@seq": "2", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Porras", "ce:indexed-name": "Porras C."}, {"@seq": "3", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Pan", "ce:indexed-name": "Pan Y."}], "et-al": null}, "ref-sourcetitle": "Cancer Prev Res (Phila)"}}, {"ref-fulltext": "Kreimer AR, Struyf F, Del Rosario-Raymundo MR, et al. Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials. Lancet Oncol 2015; 16:775-86.", "@id": "34", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: Combined analysis of data from the Costa Rica Vaccine and PATRICIA trials"}, "refd-itemidlist": {"itemid": {"$": "84937517792", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "16"}, "pagerange": {"@first": "775", "@last": "786"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.R.", "@_fa": "true", "ce:surname": "Kreimer", "ce:indexed-name": "Kreimer A.R."}, {"@seq": "2", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Struyf", "ce:indexed-name": "Struyf F."}, {"@seq": "3", "ce:initials": "M.R.", "@_fa": "true", "ce:surname": "Del Rosario-Raymundo", "ce:indexed-name": "Del Rosario-Raymundo M.R."}], "et-al": null}, "ref-sourcetitle": "Lancet Oncol"}}, {"ref-fulltext": "Dobson SR, McNeil S, Dionne M, et al. Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. JAMA 2013; 309:1793-802.", "@id": "35", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: A randomized clinical trial"}, "refd-itemidlist": {"itemid": {"$": "84877118332", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "309"}, "pagerange": {"@first": "1793", "@last": "1802"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.R.", "@_fa": "true", "ce:surname": "Dobson", "ce:indexed-name": "Dobson S.R."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "McNeil", "ce:indexed-name": "McNeil S."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Dionne", "ce:indexed-name": "Dionne M."}], "et-al": null}, "ref-sourcetitle": "JAMA"}}, {"ref-fulltext": "Smolen KK, Gelinas L, Franzen L, et al. Age of recipient and number of doses differentially impact human B and T cell immune memory responses to HPV vaccination. Vaccine 2012; 30:3572-9.", "@id": "36", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Age of recipient and number of doses differentially impact human B and T cell immune memory responses to HPV vaccination"}, "refd-itemidlist": {"itemid": {"$": "84861009178", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "30"}, "pagerange": {"@first": "3572", "@last": "3579"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.K.", "@_fa": "true", "ce:surname": "Smolen", "ce:indexed-name": "Smolen K.K."}, {"@seq": "2", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Gelinas", "ce:indexed-name": "Gelinas L."}, {"@seq": "3", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Franzen", "ce:indexed-name": "Franzen L."}], "et-al": null}, "ref-sourcetitle": "Vaccine"}}, {"ref-fulltext": "Neuzil KM, Canh dG, Thiem VD, et al. Immunogenicity and reactogenicity of alternative schedules of HPV vaccine in Vietnam: a cluster randomized noninferiority trial. JAMA 2011; 305:1424-31.", "@id": "37", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Immunogenicity and reactogenicity of alternative schedules of HPV vaccine in Vietnam: A cluster randomized noninferiority trial"}, "refd-itemidlist": {"itemid": {"$": "79953869912", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "305"}, "pagerange": {"@first": "1424", "@last": "1431"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.M.", "@_fa": "true", "ce:surname": "Neuzil", "ce:indexed-name": "Neuzil K.M."}, {"@seq": "2", "ce:initials": "D.G.", "@_fa": "true", "ce:surname": "Canh", "ce:indexed-name": "Canh D.G."}, {"@seq": "3", "ce:initials": "V.D.", "@_fa": "true", "ce:surname": "Thiem", "ce:indexed-name": "Thiem V.D."}], "et-al": null}, "ref-sourcetitle": "JAMA"}}, {"ref-fulltext": "LaMontagne DS, Thiem VD, Huong VM, Tang Y, Neuzil KM. Immunogenicity of quadrivalent HPV vaccine among girls 11 to 13 years of age vaccinated using alternative dosing schedules: results 29 to 32 months after third dose. J Infect Dis 2013; 208:1325-34.", "@id": "38", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Immunogenicity of quadrivalent HPV vaccine among girls 11 to 13 years of age vaccinated using alternative dosing schedules: Results 29 to 32 months after third dose"}, "refd-itemidlist": {"itemid": {"$": "84885038591", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "208"}, "pagerange": {"@first": "1325", "@last": "1334"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.S.", "@_fa": "true", "ce:surname": "LaMontagne", "ce:indexed-name": "LaMontagne D.S."}, {"@seq": "2", "ce:initials": "V.D.", "@_fa": "true", "ce:surname": "Thiem", "ce:indexed-name": "Thiem V.D."}, {"@seq": "3", "ce:initials": "V.M.", "@_fa": "true", "ce:surname": "Huong", "ce:indexed-name": "Huong V.M."}, {"@seq": "4", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Tang", "ce:indexed-name": "Tang Y."}, {"@seq": "5", "ce:initials": "K.M.", "@_fa": "true", "ce:surname": "Neuzil", "ce:indexed-name": "Neuzil K.M."}]}, "ref-sourcetitle": "J Infect Dis"}}, {"ref-fulltext": "Leung TF, Liu AP, Lim FS, et al. Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2-and 3-dose schedules in girls aged 9-14 years: results to month 12 from a randomized trial. Hum Vaccin Immunother 2015; 11:1689-702.", "@id": "39", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2-and 3-dose schedules in girls aged 9-14 years: Results to month 12 from a randomized trial"}, "refd-itemidlist": {"itemid": {"$": "84944459720", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "11"}, "pagerange": {"@first": "1689", "@last": "1702"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.F.", "@_fa": "true", "ce:surname": "Leung", "ce:indexed-name": "Leung T.F."}, {"@seq": "2", "ce:initials": "A.P.", "@_fa": "true", "ce:surname": "Liu", "ce:indexed-name": "Liu A.P."}, {"@seq": "3", "ce:initials": "F.S.", "@_fa": "true", "ce:surname": "Lim", "ce:indexed-name": "Lim F.S."}], "et-al": null}, "ref-sourcetitle": "Hum Vaccin Immunother"}}, {"ref-fulltext": "Angelo MG, David MP, Zima J, et al. Pooled analysis of large and long-term safety data from the human papillomavirus-16/18-AS04-adjuvanted vaccine clinical trial programme. Pharmacoepidemiol Drug Saf 2014; 23:466-79.", "@id": "40", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Pooled analysis of large and long-term safety data from the human papillomavirus-16/18-AS04-adjuvanted vaccine clinical trial programme"}, "refd-itemidlist": {"itemid": {"$": "84898023238", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "23"}, "pagerange": {"@first": "466", "@last": "479"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.G.", "@_fa": "true", "ce:surname": "Angelo", "ce:indexed-name": "Angelo M.G."}, {"@seq": "2", "ce:initials": "M.P.", "@_fa": "true", "ce:surname": "David", "ce:indexed-name": "David M.P."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Zima", "ce:indexed-name": "Zima J."}], "et-al": null}, "ref-sourcetitle": "Pharmacoepidemiol Drug Saf"}}]}}}}, "affiliation": [{"affiliation-city": "Wavre", "@id": "60111446", "affilname": "GlaxoSmithKline Pharmaceuticals SA/NV", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60111446", "affiliation-country": "Belgium"}, {"affiliation-city": "Mumbai", "@id": "60111469", "affilname": "GlaxoSmithKline Pharmaceuticals Ltd.", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60111469", "affiliation-country": "India"}, {"affiliation-city": "Taipei", "@id": "60104361", "affilname": "Cheng Hsin General Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60104361", "affiliation-country": "Taiwan"}, {"affiliation-city": "Taoyuan", "@id": "60073391", "affilname": "Chang Gung University College of Medicine", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073391", "affiliation-country": "Taiwan"}, {"affiliation-city": "Taipei", "@id": "60073385", "affilname": "National Taiwan University Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073385", "affiliation-country": "Taiwan"}, {"affiliation-city": "Milan", "@id": "60030318", "affilname": "Universit\u00e0 degli Studi di Milano", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030318", "affiliation-country": "Italy"}, {"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, {"affiliation-city": "Padua", "@id": "60027298", "affilname": "Azienda Ospedale Universit\u00e0 Padova", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027298", "affiliation-country": "Italy"}, {"affiliation-city": "Freiburg im Breisgau", "@id": "60024805", "affilname": "Universit\u00e4tsklinikum Freiburg", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024805", "affiliation-country": "Germany"}, {"affiliation-city": "Halifax", "@id": "60015913", "affilname": "Dalhousie University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015913", "affiliation-country": "Canada"}, {"affiliation-city": "Genoa", "@id": "60003700", "affilname": "Scuola di Scienze Mediche e Farmaceutiche, Universit\u00e0 Degli Studi di Genova", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003700", "affiliation-country": "Italy"}, {"affiliation-city": null, "@id": "117443926", "affilname": "Pediatric Office Dr. Med. Michael Horn", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/117443926", "affiliation-country": "Czech Republic"}, {"affiliation-city": "Sudbury", "@id": "111375275", "affilname": "Medicor Research Inc", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/111375275", "affiliation-country": "Canada"}, {"affiliation-city": "Sherbrooke", "@id": "110425674", "affilname": "Q and T Research", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/110425674", "affiliation-country": "Canada"}, {"affiliation-city": "Wurzburg", "@id": "101312952", "affilname": "Central Laboratory and Vaccination Centre", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101312952", "affiliation-country": "Germany"}], "coredata": {"srctype": "j", "eid": "2-s2.0-84988975003", "dc:description": "Background. This randomized, open trial compared regimens including 2 doses (2D) of human papillomavirus (HPV) 16/18 AS04-adjuvanted vaccine in girls aged 9-14 years with one including 3 doses (3D) in women aged 15-25 years. Methods. Girls aged 9-14 years were randomized to receive 2D at months 0 and 6 (M0,6; (n = 550) or months 0 and 12 (M0,12; n = 415), and women aged 15-25 years received 3D at months 0, 1, and 6 (n = 482). End points included noninferiority of HPV-16/ 18 antibodies by enzyme-linked immunosorbent assay for 2D (M0,6) versus 3D (primary), 2D (M0,12) versus 3D, and 2D (M0,6) versus 2D (M0,12); neutralizing antibodies; cell-mediated immunity; reactogenicity; and safety. Limits of noninferiority were predefined as <5% difference in seroconversion rate and <2-fold difference in geometric mean antibody titer ratio. Results. One month after the last dose, both 2D regimens in girls aged 9-14 years were noninferior to 3D in women aged 15-25 years and 2D (M0,12) was noninferior to 2D (M0,6). Geometric mean antibody titer ratios (3D/2D) for HPV-16 and HPV-18 were 1.09 (95% confidence interval, .97-1.22) and 0.85 (.76-.95) for 2D (M0,6) versus 3D and 0.89 (.79-1.01) and 0.75 (.67-.85) for 2D (M0,12) versus 3D. The safety profile was clinically acceptable in all groups. Conclusions. The 2D regimens for the HPV-16/18 AS04-adjuvanted vaccine in girls aged 9-14 years (M0,6 or M0,12) elicited HPV-16/18 immune responses that were noninferior to 3D in women aged 15-25 years.", "pubmed-id": "26908726", "prism:coverDate": "2016-08-15", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/84988975003", "dc:creator": {"author": [{"ce:given-name": "Thanyawee", "preferred-name": {"ce:given-name": "Thanyawee", "ce:initials": "T.", "ce:surname": "Puthanakit", "ce:indexed-name": "Puthanakit T."}, "@seq": "1", "ce:initials": "T.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Puthanakit", "@auid": "8071686900", "author-url": "https://api.elsevier.com/content/author/author_id/8071686900", "ce:indexed-name": "Puthanakit T."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/84988975003"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84988975003&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84988975003&origin=inward"}], "source-id": "22440", "citedby-count": "39", "prism:volume": "214", "subtype": "ar", "dc:title": "Randomized open trial comparing 2-dose regimens of the human papillomavirus 16/18 as04-adjuvanted vaccine in girls aged 9-14 years versus a 3-dose regimen in women aged 15-25 years", "openaccess": "1", "prism:issn": "15376613 00221899", "publishercopyright": "\u00a9 The Author 2016.", "prism:issueIdentifier": "4", "subtypeDescription": "Article", "prism:publicationName": "Journal of Infectious Diseases", "prism:pageRange": "525-536", "prism:endingPage": "536", "openaccessFlag": "true", "prism:doi": "10.1093/infdis/jiw036", "prism:startingPage": "525", "dc:identifier": "SCOPUS_ID:84988975003", "dc:publisher": "Oxford University Press"}, "idxterms": {"mainterm": [{"$": "Adjuvants, Immunologic", "@weight": "b", "@candidate": "n"}, {"$": "Adolescent", "@weight": "b", "@candidate": "n"}, {"$": "Age Factors", "@weight": "b", "@candidate": "n"}, {"$": "Aluminum Hydroxide", "@weight": "b", "@candidate": "n"}, {"$": "Antibodies, Neutralizing", "@weight": "b", "@candidate": "n"}, {"$": "Antibodies, Viral", "@weight": "b", "@candidate": "n"}, {"$": "Child", "@weight": "b", "@candidate": "n"}, {"$": "Female", "@weight": "b", "@candidate": "n"}, {"$": "Human papillomavirus 16", "@weight": "b", "@candidate": "n"}, {"$": "Human papillomavirus 18", "@weight": "b", "@candidate": "n"}, {"$": "Humans", "@weight": "b", "@candidate": "n"}, {"$": "Immunization Schedule", "@weight": "a", "@candidate": "n"}, {"$": "Lipid A", "@weight": "b", "@candidate": "n"}, {"$": "Papillomavirus Infections", "@weight": "b", "@candidate": "n"}, {"$": "Papillomavirus Vaccines", "@weight": "b", "@candidate": "n"}, {"$": "Treatment Outcome", "@weight": "b", "@candidate": "n"}, {"$": "Young Adult", "@weight": "b", "@candidate": "n"}]}, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "2-dose schedule"}, {"@_fa": "true", "$": "Adjuvant System containing 50 ?g 3-O-desacyl-4?-monophosphoryl lipid A (MPL) adsorbed on aluminum salt (500 ?g Al3+)"}, {"@_fa": "true", "$": "AS04"}, {"@_fa": "true", "$": "Cell-mediated immunity"}, {"@_fa": "true", "$": "Cervical cancer"}, {"@_fa": "true", "$": "CMI"}, {"@_fa": "true", "$": "Geometric mean antibody titer"}, {"@_fa": "true", "$": "GMT"}, {"@_fa": "true", "$": "HPV"}, {"@_fa": "true", "$": "Human papillomavirus"}, {"@_fa": "true", "$": "IgG"}, {"@_fa": "true", "$": "Immunogenicity"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Immunology and Allergy", "@code": "2723", "@abbrev": "MEDI"}, {"@_fa": "true", "$": "Infectious Diseases", "@code": "2725", "@abbrev": "MEDI"}]}, "authors": {"author": [{"ce:given-name": "Thanyawee", "preferred-name": {"ce:given-name": "Thanyawee", "ce:initials": "T.", "ce:surname": "Puthanakit", "ce:indexed-name": "Puthanakit T."}, "@seq": "1", "ce:initials": "T.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Puthanakit", "@auid": "8071686900", "author-url": "https://api.elsevier.com/content/author/author_id/8071686900", "ce:indexed-name": "Puthanakit T."}, {"ce:given-name": "Li-Min", "preferred-name": {"ce:given-name": "Li Min", "ce:initials": "L.M.", "ce:surname": "Huang", "ce:indexed-name": "Huang L.M."}, "@seq": "2", "ce:initials": "L.-M.", "@_fa": "true", "affiliation": {"@id": "60073385", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073385"}, "ce:surname": "Huang", "@auid": "7404736430", "author-url": "https://api.elsevier.com/content/author/author_id/7404736430", "ce:indexed-name": "Huang L.-M."}, {"ce:given-name": "Cheng-Hsun", "preferred-name": {"ce:given-name": "Cheng Hsun", "ce:initials": "C.H.", "ce:surname": "Chiu", "ce:indexed-name": "Chiu C.H."}, "@seq": "3", "ce:initials": "C.-H.", "@_fa": "true", "affiliation": {"@id": "60073391", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073391"}, "ce:surname": "Chiu", "@auid": "13310132600", "author-url": "https://api.elsevier.com/content/author/author_id/13310132600", "ce:indexed-name": "Chiu C.-H."}, {"ce:given-name": "Ren-Bin", "preferred-name": {"ce:given-name": "Ren Bin", "ce:initials": "R.B.", "ce:surname": "Tang", "ce:indexed-name": "Tang R.B."}, "@seq": "4", "ce:initials": "R.-B.", "@_fa": "true", "affiliation": {"@id": "60104361", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60104361"}, "ce:surname": "Tang", "@auid": "7202300282", "author-url": "https://api.elsevier.com/content/author/author_id/7202300282", "ce:indexed-name": "Tang R.-B."}, {"ce:given-name": "Tino F.", "preferred-name": {"ce:given-name": "Tino F.", "ce:initials": "T.F.", "ce:surname": "Schwarz", "ce:indexed-name": "Schwarz T.F."}, "@seq": "5", "ce:initials": "T.F.", "@_fa": "true", "affiliation": {"@id": "101312952", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101312952"}, "ce:surname": "Schwarz", "@auid": "55956700100", "author-url": "https://api.elsevier.com/content/author/author_id/55956700100", "ce:indexed-name": "Schwarz T.F."}, {"ce:given-name": "Susanna", "preferred-name": {"ce:given-name": "Susanna", "ce:initials": "S.", "ce:surname": "Esposito", "ce:indexed-name": "Esposito S."}, "@seq": "6", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60030318", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030318"}, "ce:surname": "Esposito", "@auid": "57202226520", "author-url": "https://api.elsevier.com/content/author/author_id/57202226520", "ce:indexed-name": "Esposito S."}, {"ce:given-name": "Louise", "preferred-name": {"ce:given-name": "Louise", "ce:initials": "L.", "ce:surname": "Frenette", "ce:indexed-name": "Frenette L."}, "@seq": "7", "ce:initials": "L.", "@_fa": "true", "affiliation": {"@id": "110425674", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/110425674"}, "ce:surname": "Frenette", "@auid": "36090013900", "author-url": "https://api.elsevier.com/content/author/author_id/36090013900", "ce:indexed-name": "Frenette L."}, {"ce:given-name": "Carlo", "preferred-name": {"ce:given-name": "Carlo", "ce:initials": "C.", "ce:surname": "Giaquinto", "ce:indexed-name": "Giaquinto C."}, "@seq": "8", "ce:initials": "C.", "@_fa": "true", "affiliation": {"@id": "60027298", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027298"}, "ce:surname": "Giaquinto", "@auid": "7006585659", "author-url": "https://api.elsevier.com/content/author/author_id/7006585659", "ce:indexed-name": "Giaquinto C."}, {"ce:given-name": "Shelly", "preferred-name": {"ce:given-name": "Shelly", "ce:initials": "S.", "ce:surname": "McNeil", "ce:indexed-name": "McNeil S."}, "@seq": "9", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60015913", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015913"}, "ce:surname": "McNeil", "@auid": "7004978550", "author-url": "https://api.elsevier.com/content/author/author_id/7004978550", "ce:indexed-name": "McNeil S."}, {"ce:given-name": "Paul", "preferred-name": {"ce:given-name": "Paul", "ce:initials": "P.", "ce:surname": "Rheault", "ce:indexed-name": "Rheault P."}, "@seq": "10", "ce:initials": "P.", "@_fa": "true", "affiliation": {"@id": "111375275", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/111375275"}, "ce:surname": "Rheault", "@auid": "57189256240", "author-url": "https://api.elsevier.com/content/author/author_id/57189256240", "ce:indexed-name": "Rheault P."}, {"ce:given-name": "Paolo", "preferred-name": {"ce:given-name": "Paolo", "ce:initials": "P.", "ce:surname": "Durando", "ce:indexed-name": "Durando P."}, "@seq": "11", "ce:initials": "P.", "@_fa": "true", "affiliation": {"@id": "60003700", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003700"}, "ce:surname": "Durando", "@auid": "8846475200", "author-url": "https://api.elsevier.com/content/author/author_id/8846475200", "ce:indexed-name": "Durando P."}, {"ce:given-name": "Michael", "preferred-name": {"ce:given-name": "Michael", "ce:initials": "M.", "ce:surname": "Horn", "ce:indexed-name": "Horn M."}, "@seq": "12", "ce:initials": "M.", "@_fa": "true", "affiliation": {"@id": "117443926", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/117443926"}, "ce:surname": "Horn", "@auid": "57191341897", "author-url": "https://api.elsevier.com/content/author/author_id/57191341897", "ce:indexed-name": "Horn M."}, {"ce:given-name": "Maximilian", "preferred-name": {"ce:given-name": "Maximilian", "ce:initials": "M.", "ce:surname": "Klar", "ce:indexed-name": "Klar M."}, "@seq": "13", "ce:initials": "M.", "@_fa": "true", "affiliation": {"@id": "60024805", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024805"}, "ce:surname": "Klar", "@auid": "6701599065", "author-url": "https://api.elsevier.com/content/author/author_id/6701599065", "ce:indexed-name": "Klar M."}, {"ce:given-name": "Sylviane", "preferred-name": {"ce:given-name": "Sylviane", "ce:initials": "S.", "ce:surname": "Poncelet", "ce:indexed-name": "Poncelet S."}, "@seq": "14", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60111446", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60111446"}, "ce:surname": "Poncelet", "@auid": "6506528944", "author-url": "https://api.elsevier.com/content/author/author_id/6506528944", "ce:indexed-name": "Poncelet S."}, {"ce:given-name": "St\u00e9phanie", "preferred-name": {"ce:given-name": "St\u00e9phanie", "ce:initials": "S.", "ce:surname": "De Simoni", "ce:indexed-name": "De Simoni S."}, "@seq": "15", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60111446", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60111446"}, "ce:surname": "De Simoni", "@auid": "57189925256", "author-url": "https://api.elsevier.com/content/author/author_id/57189925256", "ce:indexed-name": "De Simoni S."}, {"ce:given-name": "Damien", "preferred-name": {"ce:given-name": "Damien", "ce:initials": "D.", "ce:surname": "Friel", "ce:indexed-name": "Friel D."}, "@seq": "16", "ce:initials": "D.", "@_fa": "true", "affiliation": {"@id": "60111446", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60111446"}, "ce:surname": "Friel", "@auid": "56906794500", "author-url": "https://api.elsevier.com/content/author/author_id/56906794500", "ce:indexed-name": "Friel D."}, {"ce:given-name": "Benoit", "preferred-name": {"ce:given-name": "Benoit", "ce:initials": "B.", "ce:surname": "De Muynck", "ce:indexed-name": "De Muynck B."}, "@seq": "17", "ce:initials": "B.", "@_fa": "true", "affiliation": {"@id": "60111446", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60111446"}, "ce:surname": "De Muynck", "@auid": "25947383400", "author-url": "https://api.elsevier.com/content/author/author_id/25947383400", "ce:indexed-name": "De Muynck B."}, {"ce:given-name": "Pemmaraju V.", "preferred-name": {"ce:given-name": "Pemmaraju V.", "ce:initials": "P.V.", "ce:surname": "Suryakiran", "ce:indexed-name": "Suryakiran P.V."}, "@seq": "18", "ce:initials": "P.V.", "@_fa": "true", "affiliation": {"@id": "60111469", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60111469"}, "ce:surname": "Suryakiran", "@auid": "26022588400", "author-url": "https://api.elsevier.com/content/author/author_id/26022588400", "ce:indexed-name": "Suryakiran P.V."}, {"ce:given-name": "Marjan", "preferred-name": {"ce:given-name": "Marjan", "ce:initials": "M.", "ce:surname": "Hezareh", "ce:indexed-name": "Hezareh M."}, "@seq": "19", "ce:initials": "M.", "@_fa": "true", "affiliation": {"@id": "60111446", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60111446"}, "ce:surname": "Hezareh", "@auid": "57194243463", "author-url": "https://api.elsevier.com/content/author/author_id/57194243463", "ce:indexed-name": "Hezareh M."}, {"ce:given-name": "Dominique", "preferred-name": {"ce:given-name": "Dominique", "ce:initials": "D.", "ce:surname": "Descamps", "ce:indexed-name": "Descamps D."}, "@seq": "20", "ce:initials": "D.", "@_fa": "true", "affiliation": {"@id": "60111446", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60111446"}, "ce:surname": "Descamps", "@auid": "16311641500", "author-url": "https://api.elsevier.com/content/author/author_id/16311641500", "ce:indexed-name": "Descamps D."}, {"ce:given-name": "Florence", "preferred-name": {"ce:given-name": "Florence", "ce:initials": "F.", "ce:surname": "Thomas", "ce:indexed-name": "Thomas F."}, "@seq": "21", "ce:initials": "F.", "@_fa": "true", "affiliation": {"@id": "60111446", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60111446"}, "ce:surname": "Thomas", "@auid": "35996136600", "author-url": "https://api.elsevier.com/content/author/author_id/35996136600", "ce:indexed-name": "Thomas F."}, {"ce:given-name": "Frank", "preferred-name": {"ce:given-name": "Frank", "ce:initials": "F.", "ce:surname": "Struyf", "ce:indexed-name": "Struyf F."}, "@seq": "22", "ce:initials": "F.", "@_fa": "true", "affiliation": {"@id": "60111446", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60111446"}, "ce:surname": "Struyf", "@auid": "6603247840", "author-url": "https://api.elsevier.com/content/author/author_id/6603247840", "ce:indexed-name": "Struyf F."}]}}}